Combivair 200 Rotacaps: Each capsule contains: Budesonide B.P. 200 mcg Formoterol Fumarate (as Dihydrate) B.P. 6 mcg Combivair 400 Rotacaps: Each capsule contains: Budesonide B.P. 400 mcg Formoterol Fumarate (as Dihydrate) B.P. 6 mcg
Combivair Rotacaps is a combination of budesonide, a potent glucocrticoid and formoterol, a selective long-acting beta -agonist. 2 Budesonide is a potent glucocorticoid that binds with high affinity to the glucocorticoid receptor. It has a high ratio of topical to systemic activity. Formoterol is a very potent long-acting beta -agonist with a high intrinsic 2 activity and a rapid onset of action.
Combivair Rotacap is indicated in the regular treatment of asthma, where use of a combination (long acting beta -agonist and inhaled 2 corticosteroid) has been found to be appropriate. Symptomatic treatment of severe chronic obstructive pulmonary disease (COPD) with a history of repeated exacerbations despite regular therapy with long acting bronchodilators. It is not indicated for the relief of acute bronchospasm.
1. Combivair 200 Rotacaps: Blister pack of 3 X 10’s Rotacaps.
2. Combivair 400 Rotacaps: Blister pack of 3 X 10’s Rotacaps.
Patients should consult with their physician before taking any medicine.